Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome.

[1]  R. Newcombe,et al.  Results of a national training programme in sentinel lymph node biopsy for breast cancer , 2013, The British journal of surgery.

[2]  E. Rutgers,et al.  Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  M. Brennan,et al.  Accuracy of sentinel lymph node biopsy in large and multifocal/multicentric breast carcinoma--a systematic review. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[5]  T. Julian,et al.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.

[6]  T. Julian,et al.  Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Norman Wolmark,et al.  Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection , 2010, Journal of surgical oncology.

[8]  E. Rutgers,et al.  UvA-DARE ( Digital Academic Repository ) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS , 2010 .

[9]  E. Rutgers,et al.  Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  T. Meretoja,et al.  Sentinel Node Biopsy in Breast Cancer Patients with Large or Multifocal Tumors , 2009, Annals of surgical oncology.

[11]  I. V. D. van der Ploeg,et al.  Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  R. Aft,et al.  Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence. , 2008, American journal of surgery.

[13]  G. Dionigi,et al.  Axillary sentinel lymph node biopsy: an overview. , 2008, International journal of surgery.

[14]  T. Julian,et al.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.

[15]  Kelly K Hunt,et al.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Ingravallo,et al.  Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer. , 2007, Breast.

[17]  P. Christiansen,et al.  Sentinel lymph node biopsy technique and multifocal breast cancer – The Aarhus experience , 2007, Acta oncologica.

[18]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[19]  R. Newcombe,et al.  Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase , 2006, Breast Cancer Research and Treatment.

[20]  D. Krag,et al.  Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer , 1998, Annals of Surgical Oncology.

[21]  John Boyages,et al.  Multifocal and multicentric breast cancer: does each focus matter? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  David Bouwman,et al.  Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma , 2004, Cancer.

[23]  R. Newcombe,et al.  Predictors of non-sentinel lymph node metastasis in breast cancer patients. , 2004, European journal of cancer.

[24]  U. Chetty,et al.  Sentinel lymph node biopsy in patients with multifocal breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  V. Ozmen,et al.  Increased False Negative Rates in Sentinel Lymph Node Biopsies in Patients with Multi-Focal Breast Cancer , 2002, Breast Cancer Research and Treatment.

[26]  Hiram S. Cody,et al.  A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy , 2003, Annals of Surgical Oncology.

[27]  H. Cody,et al.  The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. , 2003, Journal of the American College of Surgeons.

[28]  E. Rutgers,et al.  Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[30]  M. Wallack,et al.  Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  David Bouwman,et al.  Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma , 2002, Cancer.

[32]  J. Frisell,et al.  Multicentre study of detection and false‐negative rates in sentinel node biopsy for breast cancer , 2001, The British journal of surgery.

[33]  E. Rutgers,et al.  The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials. , 2001, Surgical oncology clinics of North America.

[34]  Alice Chung,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.